北交所打新“卷”出新高度：丹娜生物正股门槛突破850万元

Core Insights - The recent IPO of Danna Biotechnology on the Beijing Stock Exchange has sparked significant market discussion due to its record-high subscription threshold of 8.5141 million yuan, the highest in the exchange's history [1] - The number of online subscription accounts reached 553,200, with total frozen funds amounting to 613.017 billion yuan, yet only the top 13% of accounts were able to secure 100 shares [1] - Despite the high subscription threshold, Danna Biotechnology's maximum subscription amount of 6.156 million yuan is still below the threshold, indicating that even top-tier investors cannot directly obtain a full allocation of shares and must rely on subsequent fractional share distribution [1] - The trend of increasing interest in IPOs on the Beijing Stock Exchange is evident, although the financial barrier for ordinary investors remains high; however, employees of Danna Biotechnology managed to secure 85% of the total shares through a strategic placement plan [1]